Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Comparative Assessment of Stem Cell Activity on ETTES and Composite of ETTES & RGDS Peptide Amphiphiles for Corneal Tissue Engineering
Author Affiliations & Notes
  • cagla erdas
    Bioscience Institute, Newcastle University, Newcastle upon Tyne, Newcastle Upon and Tyne, United Kingdom
  • Che John Connon
    Bioscience Institute, Newcastle University, Newcastle upon Tyne, Newcastle Upon and Tyne, United Kingdom
  • Footnotes
    Commercial Relationships   cagla erdas None; Che Connon None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 4492. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      cagla erdas, Che John Connon; Comparative Assessment of Stem Cell Activity on ETTES and Composite of ETTES & RGDS Peptide Amphiphiles for Corneal Tissue Engineering. Invest. Ophthalmol. Vis. Sci. 2024;65(7):4492.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The scarcity of corneal donors has fueled a high demand for substitutes. Peptide amphiphiles(PAs) can be designed to influence cellular behaviour and are instrumental in the development of scaffolds for corneal regeneration. This study investigates the influence of incorporating RGDS PAs into ETTES PAs at different concentrations on the metabolic activity of stem cells, with a specific application in corneal tissue engineering.

Methods : 1.25 mM of 100% C16-ETTES and 1.25 mM of 80% C16-ETTES + 20% C16 RGDS were separately dissolved in double-distilled water. Subsequently, each solution was diluted to concentrations of 125 µM, 12.5 µM, and 1.25 µM. 3 biological replicates of 24 well plates were coated with ETTES PAs and the composite of RGDS & ETTES PAs at concentrations of 1.25mM, 125 µM, 12.5 µM and 1.25 µM. Adipose Stem cells (ASCs) were incubated on these coatings for 3 days, and their metabolic activities were quantitatively measured as florescent intensity using Alamar Blue Assay in comparison to the control groups incubated on uncoated 24 well plates. Two-way ANOVA was used for statistical analysis. Moreover, ASC proliferation and morphology were assessed using advanced microscopy techniques with Leica Microsystems.

Results : The hybrid formulation, 80% ETTES & 20% RGDS PAs demonstrated superior performance in sustaining stem cell viability compared to 100% ETTES PAs across various concentrations (125 µM, 12.5 µM, and 1.25 µM) and at two distinct time points. This formulation exhibited enhanced metabolic activity at these concentrations relative to 100% ETTES. While variations among concentrations (125 µM, 12.5 µM, and 1.25 µM) did not yield significant differences, it is noteworthy that 1.25 mM failed to sustain cell viability in both formulations. This outcome underscores the importance of integrating RGDS in the design of PA scaffolds to enhance cellular adhesion and viability. Furthermore, it emphasizes the optimal threshold concentration, observed to be under 1.25 mM for effectiveness.

Conclusions : The study emphasizes the importance of PA composition in influencing cellular responses. The hybrid formulation outperformed 100% ETTES, offering valuable insights for optimizing peptide amphiphiles in corneal tissue engineering, stressing the need to consider both composition and concentration in scaffold design.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×